Institutional Profile: The Einstein Center for Epigenomics: Studying the Role of Epigenomic Dysregulation in Human Disease
Abstract
There is increasing interest in the role of epigenetic and transcriptional dysregulation in the pathogenesis of a range of human diseases, not just in the best-studied example of cancer. It is, however, quite difficult for an individual investigator to perform these studies, as they involve genome-wide molecular assays combined with sophisticated computational analytical approaches of very large datasets that may be generated from various resources and technologies. In 2008, the Albert Einstein College of Medicine in New York, USA established a Center for Epigenomics to facilitate the research programs of its investigators, providing shared resources for genome-wide assays and for data analysis. As a result, several avenues of research are now expanding, with cancer epigenomics being complemented by studies of the epigenomics of infectious disease and a neuroepigenomics program.
Related Papers
- → DNA methylation in osteoarthritic chondrocytes: a new molecular target(2006)78 cited
- → Toward an integrated genetic and epigenetic approach to Alzheimer's disease(2011)44 cited
- → Genetic and Environmental Impacts on DNA Methylation Levels in Twins(2015)39 cited
- → Early Nutritional Influences on Human Developmental Epigenetics(2015)
- [Tobacco and DNA methylation: the case for epigenetic alterations].(2021)